Markets Wired

I commend the House Energy and Commerce Committee for adopting the Protecting Consumer Access to Generic Drugs Act (H.R.1706) as an amendment to the omnibus health reform legislation. If enacted into law, this measure will put an end to the sweetheart deals between brand and generic pharmaceutical companies that force consumers to wait –sometimes years– for more affordable generic drugs. We estimate that this critical provision will save consumers about $3.5 billion per year and advance the cause of affordable health care for all Americans.

(PayForDelay.wpd)